C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media

More topics under "C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media" (918,689)
C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
C12N 11 - Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof (12,439)
C12N 13 - Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves (3,958)
C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
C12N 3 - Spore-forming or isolating processes (415)
C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)

Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
11/2006
11/16/2006	US20060258000 Use of steady-state oxygen gradients to modulate animal cell functions
11/16/2006	US20060257918 Polynucleotide encoding a novel human G-protein coupled receptor variant of the relaxin receptor HGPRBMY5v1, and variants thereof
11/16/2006	US20060257908 Method for two- and three-dimensional microassembly of patterns and structures
11/16/2006	US20060257872 Cell lines and host nucleic acid sequences related to infectious disease
11/16/2006	US20060257464 Comprises cationic phospholipid derivatives which complex with DNA
11/16/2006	US20060257398 humanized, chimeric and human anti-CD19 antibodies, anti-CD19 antibody fusion proteins, and fragments thereof that bind to a human B cell marker; B-cell malignancies and autoimmune diseases
11/15/2006	EP1720984A1 Methods and compositions for treatment or prevention of secondary ischemic injury
11/15/2006	EP1613727A4 Approaches to identifying genetic traits in animals
11/15/2006	EP1488335A4 Optimization of crossover points for directed evolution
11/15/2006	CN1863921A Methods for expression and purification of immunotoxins
11/15/2006	CN1863552A Tyrosinase mutant and methods of use thereof
11/14/2006	US7135549 Can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 184P1E2 can be used in active or passive immunization
11/14/2006	US7135055 Non-alloying core shell nanoparticles
11/09/2006	WO2005054441A3 Device for immobilizing chemical and biomedical species and methods of using same
11/09/2006	WO2004067715A3 Anonymous testing system and kit
11/09/2006	US20060252923 Nucleotide compositions comprising photocleavable markers and methods of preparation thereof
11/09/2006	US20060252129 Human coagulation Factor VII variants
11/09/2006	US20060252100 Can be used for the treatment of diabetes or for delaying the onset of diabetes
11/09/2006	US20060252053 Drug screening; ability to block apoptosis and promote cell growth and transformation; cancer; inhibition of caspase-7 polypeptide
11/08/2006	EP1718321A2 Anti-hiv-1 compounds based upon a conserved amino acid sequence shared by gp160 and the human cd4 protein
11/08/2006	EP1678315A4 Engineered zinc finger proteins for regulation of gene expression
11/08/2006	EP1644538A4 Methods and compositions for detecting promoter activity and expressing fusion proteins
11/08/2006	EP1636360A4 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site
11/08/2006	EP1481091A4 Multivariate random search method with multiple starts and early stop for identification of differentially expressed genes based on microarray data
11/08/2006	CN1860231A Transcription factors
11/08/2006	CN1860221A Process for the biological production of 1,3-propanediol with high yield
11/07/2006	US7132257 Production or aromatic carotenoids in gram negative bacteria
11/07/2006	US7132240 Obtaining chromosomal DNA from plants for preparing expression vectors comprising artificial chromosomes
11/02/2006	WO2005028624A3 Molecular scaffolds for kinase ligand development
11/02/2006	WO2004096996A3 Modulation of glucagon receptor expression
11/02/2006	US20060248611 Altered fad2 and fad3 genes in brassica and the molecular marker-assisted detection thereof
11/02/2006	US20060247193 Regulation of gene expression by dna interference
11/02/2006	US20060246509 Unnatural reactive amino acid genetic code additions
11/02/2006	US20060246446 in vitro methods of expansion and propagation of undifferentiated progenitor cells containing Islet1, a marker unique to proliferating cardiac stem cells; done without differentiation to provide cardiac repair or improve cardiac function
11/02/2006	US20060246445 Aflp-based method for integrating physical and genetic maps
11/02/2006	US20060246440 Methods for producing zinc finger proteins that bind to extended dna target sequences
11/02/2006	US20060246037 Neuroprotective effects of atf6
11/02/2006	EP1716227A2 Methods of identifying putative gene products by interspecies sequence comparison and biomolecular sequences uncovered thereby
11/02/2006	EP1628953A4 Process for preparing reverse transcriptase inhibitors
11/02/2006	EP1597383A4 Variants of cytochrome c and methods of diagnosis of thrombocytopenia
10/2006
10/26/2006	WO2006084953A9 Novel microbial enzymes and their use
10/26/2006	WO2005054427A3 Target sequences for synthetic molecules
10/26/2006	WO2005042708A3 METHOD OF DESIGNING siRNAS FOR GENE SILENCING
10/26/2006	US20060242737 Modulation of flowering time by the pft1 locus
10/26/2006	US20060242722 Genetic manipulation of nonhuman animals to be used for xenotransplantation; null swine; obtaining a line of cells from a GGTA1 heterozygous swine, enriching them by treatment with agents that specifically bind alpha (1,3)-galactose epitope and deplete cells that do not, scanning for viable cells
10/26/2006	US20060242719 Nucleotide sequences of shrimp beta-actin and actin promoters and their use in gentic transformation technology
10/26/2006	US20060241072 Oligomeric compounds for use in gene modulation
10/26/2006	US20060241071 Quaternary ammonium compound having ester and/or amide groups; cationic amphiphilic molecule or macromolecule that transforms from a cationic entity to an anionic, neutral, or zwitterionic entity by a chemical, photochemical, or biological reaction and its use for delivery of nucleic acids
10/26/2006	US20060241033 Markers for pre-cancer and cancer calls and the method to interfere with cell proliferation therein
10/26/2006	US20060240530 cDNA of a severe acute respiratory syndrome (SARS) coronavirus, recombinant SARS coronavirus vectors, and SARS coronavirus replicon particles
10/26/2006	US20060240520 monitoring the efficacy of a BAFF-R (a B-cell activating factor belonging to the Tumor Necrosis Factor family) antagonist in the treatment of a disease or disorder associated with aberrant levels of B-cells or B-cell activity
10/26/2006	US20060240519 Novel receptor nucleic acids and polypeptides
10/26/2006	US20060240518 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells
10/26/2006	US20060240517 Novel receptor nucleic acids and polypeptides
10/26/2006	US20060240058 Combinatorial surface chip compositions for selection, differentiation and propagation of cells
10/26/2006	US20060240025 isolated polypeptide encoded by an isolated nucleic acid molecule as antitumor biodrugs; modulation of chemokine, cytokine expression
10/26/2006	US20060240024 T cell regulation
10/25/2006	EP1715045A2 Recombinant antibodies for human therapy
10/25/2006	EP1713900A2 Methods and systems for annotating biomolecular sequences
10/25/2006	EP1670948A4 GENE MODULATION BY RB2/p130 EXPRESSION
10/25/2006	CN1852986A Production of polyunsaturated fatty acids in oleaginous yeasts
10/25/2006	CN1852736A Immunoglobulin chimeric monomer-dimer hybrids
10/25/2006	CN1852734A Consensus/ancestral immunogens
10/24/2006	US7125855 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
10/24/2006	US7125672 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts
10/19/2006	WO2004106491A8 Angiogenin-based hiv-1 therapies
10/19/2006	US20060235625 Methods and materials for canine breed identification
10/19/2006	US20060235220 Dipeptide nitriles
10/19/2006	US20060234917 glycoprotein comprising the extracellular domain of a non-naturally occurring BAFF-R; BAFF (B-cell-activating factor of the TNF family); immunologic, autoimmune diseases, cancers, virus-associated diseases, renal, hypertensive diseases, conditions requiring immunosuppression, inflammation
10/19/2006	US20060234364 Genetically modified yeast species and fermenation processes using genetically modified yeast
10/19/2006	US20060234238 Polymerase-based protocols for generating chimeric oligonucleotides
10/19/2006	US20060234226 Non-affinity purification of proteins
10/18/2006	EP1711812A2 Methods and materials for canine breed identification
10/18/2006	EP1711524A2 Polynucleotide encoding a novel human g-protein coupled receptor variant of the relaxin receptor, hgprbmy5v1, and variants thereof
10/18/2006	EP1711207A2 Interferon alpha antibodies and their uses
10/18/2006	EP1711196A2 Inhibitors of type 2 vascular endothelial growth factor receptors
10/18/2006	EP1552022A4 Identification of oligonucleotides for the capture, detection and quantitation of hepatitis a viral nucleic acid
10/18/2006	EP1546396A4 Manufacturing method and readout system for biopolymer arrays
10/18/2006	CN1849397A Insecticidal proteins secreted from bacillus thuringiensis and uses therefor
10/18/2006	CN1849069A Modified oligonucleotides for telomerase inhibition
10/17/2006	US7122648 Isolated nucleic acids; binding to antibody; diagnosis of muscular disorders
10/12/2006	WO2005051320A3 Gcks as modifiers of branching morphogenesis and methods of use
10/12/2006	WO2005012479A3 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
10/12/2006	WO2004083389A3 Mbcats as modifiers of the beta-catenin pathway and methods of use
10/12/2006	US20060229266 Silencing of tgf-beta receptor type II expression by sirna
10/12/2006	US20060228731 Compositions and methods of using a synthetic DNase I
10/12/2006	US20060228682 Three dimensional model for protein or part of protein structure
10/12/2006	US20060228343 Cardiac glycoside resistant non-immunogenic selection marker
10/11/2006	EP1709194A2 DELIVERY OF DNA OR RNA VIA GAP JUNCTIONS FROM HOST CELLS TO TARGET CELLS AND A CELL-BASED DELIVERY SYSTEM FOR ANTISENSE OR SiRNA
10/11/2006	EP1709152A2 Molecular signature of the pten tumor suppressor
10/11/2006	EP1709151A2 Compositions and methods for propagation of neural progenitor cells
10/11/2006	EP1709150A2 Use of notch pathway interfering agents for treatment of plasma cell disorders
10/11/2006	EP1709059A2 Methods of designing, synthesizing, and propagating reference nucleic acids
10/11/2006	EP1708703A2 Chemokine receptor binding compounds
10/11/2006	EP1708560A2 Corn plant mon88017 and compositions and methods for detection thereof
10/11/2006	CN1845978A Organic cooling medium and its uses
10/11/2006	CN1845751A Stationary phases and a purification process using the stationary phases
10/11/2006	CN1279165C Inflenza vaccine composition
10/10/2006	US7119188 N-carbobenzyloxy (N-CBZ)-deprotecting enzyme and uses therefor
10/10/2006	US7118750 Modified TNF-alpha molecules, DNA encoding such and vaccines comprising such modified TNF-alpha and DNA

1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 100